Cubist Systematic Strategies’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.65M Buy
20,700
+2,800
+16% +$239K 0.01% 1682
2025
Q2
$1.63M Buy
17,900
+5,800
+48% +$529K 0.01% 1670
2025
Q1
$1.13M Sell
12,100
-11,200
-48% -$1M 0.01% 1747
2024
Q4
$2.12M Buy
23,300
+1,900
+9% +$181K 0.01% 1316
2024
Q3
$2.22M Buy
21,400
+8,700
+69% +$887K 0.01% 1367
2024
Q2
$1.23M Sell
12,700
-46,900
-79% -$4.33M 0.01% 1622
2024
Q1
$5.37M Sell
59,600
-40,800
-41% -$3.46M 0.03% 921
2023
Q4
$8M Sell
100,400
-4,500
-4% -$338K 0.05% 578
2023
Q3
$7.46M Buy
104,900
+15,700
+18% +$1.17M 0.06% 526
2023
Q2
$6.87M Sell
89,200
-17,900
-17% -$1.39M 0.05% 653
2023
Q1
$8.05M Buy
+107,100
New +$7.96M 0.05% 579

Other funds holding CL

Cubist Systematic Strategies's CL Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Colgate-Palmolive (CL) in Q3 2025: 59,238 shares worth $4.74M. The stake represents 0.02% of the portfolio and ranks #995 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in CL as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in CL in Q2 2014 and has held it in 40 quarters since. The position peaked at $42.1M in Q2 2023. 1,842 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Cubist Systematic Strategies held 59,238 shares of Colgate-Palmolive worth $4.74M as of Q3 2025.
  • Colgate-Palmolive was a new Cubist Systematic Strategies position in Q3 2025.
  • Colgate-Palmolive made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #995 holding.
  • Cubist Systematic Strategies first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 40 quarters since.
  • Cubist Systematic Strategies's Colgate-Palmolive position peaked at $42.1M in Q2 2023.
  • 1,842 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.